search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


EUMIC transport study


- candidate number21139
- NTR NumberNTR4937
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR10-dec-2014
- Secondary IDs145085  (MUMC+)
- Public TitleEUMIC transport study
- Scientific TitleQuality and efficacy of interclinical critical transport in the Euregion Meuse-Rhine: An international, prospective, observational, multicentre study
- ACRONYMQUIT EMR
- hypothesis1) Transports with high standard ground transport systems compared with medium and/or low standard ground transport systems will show for the whole population at least trends and for subgroups significant differences in „XThe developed QUIT EMR score and or „XNumber and severity of adverse events and or „XNumber of interventions 2)Negative transport outcome leads to a higher 24-hour post-transport morbidity 3)Pre-transport data that indicate a benefit of transport with a high standard transport system can be detected and defined. 4)Pre- transport data that indicate 24-hour post-transport mortality will be detected and defined.
- Healt Condition(s) or Problem(s) studiedcritical ill transportation, interclinical transport, MICU
- Inclusion criteriaAdult patients (18 years) which undergo an interclinical transport with indication for a physician supervised transport within the study region (MICU region Maastricht, district of Aachen, City of Aachen, district of Heinsberg and Düren).
- Exclusion criteriaAge < 18 years Interclinical transport without indication for direct supervision of a physician
- mec approval receivedyes
- multicenter trialyes
- randomisedno
- group[default]
- Type[default]
- Studytypeobservational
- planned startdate 1-apr-2015
- planned closingdate31-jan-2017
- Target number of participants3000
- Interventionsnone
- Primary outcomeTo validate the QUIT EMR score in a prospective multicentre study by comparing three defined levels of transport systems.
- Secondary outcomea)To analyse if negative transport outcome (measured by QUIT EMR score) influences 24-hour post transport morbidity (measured by SEMROS). b)To detect patients’ characteristics that define the patients’ needs in terms of level of transportation facility. c)To detect predictive outcome parameters concerning 24 hours post transport mortality
- Timepointsnone
- Trial web siteeumic.eu
- statusplanned
- CONTACT FOR PUBLIC QUERIES U. Strauch
- CONTACT for SCIENTIFIC QUERIES U. Strauch
- Sponsor/Initiator Maastricht University Medical Center (MUMC+)
- Funding
(Source(s) of Monetary or Material Support)
Project EMRIC+ (funded by european union, state of Limburg, state of North Rhine Westpalia, State of Wallonia and others)
- Publications
- Brief summary
- Main changes (audit trail)
- RECORD10-dec-2014 - 27-feb-2016


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl